The Botswana Harvard AIDS Institute Partnership (BHP) was established 20 years ago to help combat HIV/AIDS at the epicenter of the epidemic. At the time, about 37% of pregnant women in Botswana were infected with HIV. Dr. Joseph Makhema was a young physician working what seemed like unending hours at the public hospital in Gaborone, where effective treatment was not yet available. Today, Dr. Makhema is the CEO of the Institute he played an important role in establishing. Martha Henry, Executive Director of HAI, spoke with him about the BHP’s history and future. Continue reading
Opioid abuse has become a major public health problem in the U.S. According to the Centers for Diseases Control (CDC), overdose deaths involving prescription opioids increased to about 19,000 deaths in 2014, more than four times the number in 2000. In 2012, according to the National Institute on Drug Abuse, an estimated 2.1 million people suffered from substance use disorders related to prescription opioid pain relievers, with an estimated 467,000 addicted to heroin.
Heroin and other opioids are often injected. According to Harm Reduction International, HIV prevalence is 28 times higher in people who inject drugs compared with the rest of the population. Read more.
By Belinda O’Donnell
At a time where the push for full inclusion of LGBT people is gaining ground at a remarkable pace, it’s important to acknowledge that there is still not a single country where LGBT people are not threatened and objectified, have their abilities and contributions discounted, and are subjected to violence because of their perceived or actual LGBT status. Because of this reality, it’s not surprising that LGBT people often struggle to access quality healthcare. And yet as UNAIDS deputy executive director Dr. Luiz Loures notes, “Non-discrimination in health care settings is urgent in order to end the AIDS epidemic.”
Belinda O’Donnell spoke with Monica Kriete, a fierce LGBT health advocate, a former facilitator of a discussion group for queer women in their twenties at the DC LGBT Center, and a first-year MPH student at the Harvard T.H. Chan School of Public Health. They talked about how to make health-care settings more inclusive for LGBT people, as well as what it’s like to commit to a career in public health at such a charged political moment in the United States.
Research to end the AIDS epidemic goes on all day (and many nights) at the Harvard T.H. Chan School of Public Health. To mark World AIDS Day 2016, we bring you a sampling of the important work being done around the world by our scientists, clinicians, students and staff.
World AIDS Day Symposium
Thursday, December 1, 2016
8:00 – 9:30 am • Coffee & Breakfast Provided
Harvard T.H. Chan School of Public Health • Kresge G2
In 2015, experts were caught off guard when an HIV epidemic exploded in a rural Indiana town. Prescription painkillers were being ground up and injected, often with shared needles, an easy route for HIV transmission.
The U.S. is in the midst of an unprecedented opioid epidemic. According to the Centers for Disease Control and Prevention, 1,379 people died of an overdose in Massachusetts last year. The threat of another HIV outbreak among injection drug users looms, not only in the U.S., but around the world. The symposium will address the current opioid crisis and ways to limit or prevent future HIV outbreaks.
Her life has been anything but linear. Born in Beijing, Amy Wu grew up in Oregon, performed as a concert pianist in her teens, majored in biochemistry at Harvard, conducted HIV research in China and Botswana, and now works 80-hour weeks as a vice president at a tech startup. She also serves on HAI’s International Advisory Council.
Martha Henry, Executive Director of HAI, reached Amy by phone in a conference room in Manhattan.
You were one of the first Harvard undergrads to spend a semester in Botswana conducting HIV research. Almost ten years later, how do you view that experience?
“Good science requires good record keeping.”¹
The laboratory notebook has changed little over hundreds of years. Part journal, part scrapbook, it is a record of both what a researcher thinks and what she does. It documents her day-to-day hypotheses, experiments, observations, analyses, and conclusions. Think of Leonardo da Vinci’s sketches of a flying machine or Darwin’s detailed field notes from his voyage on the Beagle. In today’s modern laboratories, researchers use the same kind of bound paper notebook to document their work.
The 1876 notebook of Alexander Graham Bell, who patented the first practical telephone.
Dr. Virginia “Ginny” Bond is a Social Anthropologist and Associate Professor at the London School of Hygiene & Tropical Medicine. Based in Zambia, she heads the social science unit at Zambart. She is the lead social scientist for PopART (Population Effects of Antiretroviral Therapy to Reduce HIV Transmission) a large community-randomized trial being carried out in 21 communities in South Africa and Zambia. The trial is designed to evaluate the impact of a universal test-and-treat intervention on population-level HIV incidence. Similar to HAI’s Botswana Combination Prevention Project, the goal of PopART is to dramatically reduce the number of new HIV infections.
Martha Henry, Executive Director of HAI, spoke over Skype with Dr. Bond in Zambia.
Wei-Kung Wang’s Work on Flaviviruses
Timing is everything. Dr. Wei-Kung Wang returned to Harvard in early March, just as the World Health Organization (WHO) declared the Zika outbreak to be a Public Health Emergency of International Concern.
Susan Butler Plum is the founding director of the Skadden Fellowship Foundation, which every year awards two-year grants to 25 public-interest attorneys. She also serves on a number of boards, including HAI’s International Advisory Council. She recently spoke by phone with Martha Henry, HAI’s Executive Director.
When people ask what your job is, how do you reply?
I say that I’m the founder and director of a foundation that makes grants for young lawyers to work with the poor. Most of our applications come from the best law schools in America. Probably 45 to 50 applications a year come from the top of the class at Harvard Law School. Continue reading